Alkyl Amines Chemicals (506767) Q4 25/26 earnings summary

Executive summary

• FY 2026 saw flat top-line and bottom-line performance, with both revenue and profit remaining within ±1% of last year, reflecting a challenging market environment.

• Audited financial results for the quarter and year ended March 31, 2026, were approved with an unmodified audit opinion from the statutory auditor.

• Market share was retained or slightly increased across key markets despite operational disruptions in March due to ammonia sourcing issues linked to geopolitical events.

• A final dividend of Rs. 10 per equity share (500%) for FY 2025-26 was recommended, subject to shareholder approval.

• Management expressed cautious optimism for the future, expecting better performance ahead after a difficult three-year period.

Financial highlights

• Revenue from operations for FY 2025-26 was Rs. 1,535.85 crore, compared to Rs. 1,571.82 crore in FY 2024-25.

• Net profit after tax for FY 2025-26 was Rs. 180.00 crore, down from Rs. 186.11 crore in FY 2024-25.

• Volume and value both declined by about 1%, resulting in a combined 2% drop compared to the previous year.

• Finished goods prices increased by 30–40% year-over-year, especially in acetonitrile, driven by higher raw material costs.

• Margins temporarily improved due to inventory of lower-cost raw materials, but are expected to normalize as competition adjusts.

Outlook and guidance

• Volume growth for the coming year is expected to be in the 5–10% range, in line with broader industry trends.

• Management anticipates some improvement in margins, but not a dramatic or sustained increase year-over-year.

• Top-line growth will be supported by elevated selling prices, but volume growth will remain moderate.

• The company continues to monitor regulatory changes, especially regarding new labour codes, and will adjust accounting as needed.